36 61

Cited 0 times in

담관암의 선행 항암 치료와 수술 후 보조 항암 치료

Other Titles
 Neoadjuvant and Adjuvant Chemotherapy for Cholangiocarcinoma 
 Korean Journal of Pancreas and Biliary Tract (대한췌담도학회지), Vol.27(3) : 111-115, 2022-07 
Journal Title
Korean Journal of Pancreas and Biliary Tract(대한췌담도학회지)
Issue Date
Cholangiocarcinoma ; Neoadjuvant therapy ; Chemotherapy ; adjuvant
Cholangiocarcinoma consists of a heterogeneous group of aggressive and rare malignancies that arise from the bile ducts outside or inside the liver. Although surgical resection remains the only potential curative treatment option for patients with cholangiocarcinoma, curative surgery is only possible in a small number of cases. Furthermore, recurrence rates are high even among patients who undergo surgical resection. Unfortunately, a significant proportion of patients present with locally advanced, unresectable disease. Recently, neoadjuvant chemotherapy has emerged as a promising method to identify patients with poor prognosis, avoiding pathological and non-therapeutic resection, as well as potentially downstaging tumors which cannot be resected initially. This therapeutic strategy has the potential to improve local and distant control, to achieve R0 resection and to prevent distant metastasis. However, few data are currently available supporting neoadjuvant chemotherapy in cholangiocarcinoma and several questions remains unanswered. Adjuvant chemotherapy is administered after surgery to eradicate any remaining cancer cells with the goal of reducing the chances of recurrence. And chemotherapy is also frequently used in cholangiocarcinoma as an adjunct to surgical resection, but the appropriate sequence of chemotherapy with surgery is unclear.
Files in This Item:
T9992022937.pdf Download
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
Yonsei Authors
Lee, Hee Seung(이희승) ORCID logo https://orcid.org/0000-0002-2825-3160
사서에게 알리기


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.